HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wellness Launches: Rebbl's Elixirs, Cannovia's Founder Series, More

Executive Summary

Healthycell Bioactive microgel supplements use Bioactive Gel delivery system; herbal beverage firm founded by anti-human trafficking non-profit launches elixirs; more CBD- and hemp-containing drinks and supplements roll out from Cannovia, other firms; and more wellness launch news.

You may also be interested in...



HBW Market News: DSM Taps Co-CEOs, Bayer Consumer Ex-US Changes Ad Firm, Recover 180° Sponsors Champ, More

Former PepsiCo exec Beraud's Sh’nnong Beverage launches Ma Functional Iced Teas with CBD+ Natural Botanicals; Chobani expands beyond yogurt with oat-based products; Recover 180° sponsors boxer Deontay Wilder; Mighty Self Balance CBD targets inflammation; Oki CBD drinks reach Florida; Bayer consumer taps ad firm MullenLowe; and Royal DSM will have co-CEOs when CEO Sijbesma leaves.

Wellness Industry News: Rain Forest In US, Napa Hills Resveratrol Sparkle, More

Peru's Ran Forest launches in US; Rebbl Collective takes on climate change, human trafficking; Napa Hills sparkles with resveratrol; more Forslean in Le-Vel's Thrive DFL; LeanLife expands testing pact with Ecovatec; and PureFormulas deploys Linc Global e-commerce tech.

Could ICER Outreach To US FDA Lead To Better Cost Effectiveness Analyses?

To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.

Topics

UsernamePublicRestriction

Register

RS148765

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel